Gerameda - Company finances
|
EUR
|
2018
From: 2018-06-20
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 0 | 0 | 11,840 | 103,515 | 257,234 | 423,959 | 582,139 | 516,207 |
| Profit before tax | 0 | 0 | -4,403 | 47,679 | 122,884 | 271,382 | 402,288 | 316,468 |
| Net profit | 0 | 0 | -4,403 | 41,188 | 104,451 | 271,382 | 402,288 | 316,468 |
| Equity | 2,500 | 2,500 | -1,904 | 45,775 | 137,278 | 197,771 | 309,054 | 157,359 |
| Liabilities | 0 | 0 | 7,114 | 21,376 | 3,103 | 5,958 | 3,595 | 661 |
| Non-current assets | 0 | 0 | 2,156 | 2,197 | 11,031 | 7,606 | 30,184 | 27,530 |
| Current assets | 2,500 | 2,500 | 3,054 | 64,954 | 129,350 | 196,123 | 282,465 | 130,490 |
| Total assets | 2,500 | 2,500 | 5,210 | 67,151 | 140,381 | 203,729 | 312,649 | 158,020 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 59,109 | 116,990 | 165,454 |
| Social insurance contributions | - | - | - | - | - | 20,079 | 21,706 | 27,200 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | - | - | +774.3% | +148.5% | +64.8% | +37.3% | -11.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.0% | 0.0% | -84.5% | 61.3% | 74.4% | 133.2% | 128.7% | 200.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.0% | 0.0% | - | 90.0% | 76.1% | 137.2% | 130.2% | 201.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | -37.2% | 39.8% | 40.6% | 64.0% | 69.1% | 61.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | -37.2% | 46.1% | 47.8% | 64.0% | 69.1% | 61.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | 0.5 | 0.0 | 0.0 | 0.0 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | 779 | 5,646 | 12,011 | 18,366 | 25,128 | 24,292 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Gerameda - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-02-10 | 2025-02-10 | 3.45 |
| 2025-01-16 | 2025-02-02 | 3.45 |
| 2022-09-16 | 2022-10-05 | 2.94 |
| 2022-04-19 | 2022-05-11 | 0.01 |
| 2021-12-16 | 2022-01-13 | 0.01 |
Gerameda - VMI tax arrears
As of 2026-09-14, the amount of overdue STI tax debt of the company Gerameda is: 5 €
| From | To | Overdue, € |
|---|---|---|
| 2026-09-06 | 2026-09-14 | 5.06 |
| 2026-08-31 | 2026-08-31 | 5.79 |
| 2026-08-02 | 2026-08-30 | 0.35 |
| 2026-02-07 | 2026-03-02 | 0.45 |
| 2026-02-03 | 2026-02-06 | 0.06 |
| 2026-01-29 | 2026-02-02 | 0.45 |
| 2026-01-23 | 2026-01-28 | 6.98 |
| 2026-01-08 | 2026-01-15 | 16.68 |
| 2026-01-01 | 2026-01-07 | 16.72 |
| 2025-12-19 | 2025-12-31 | 4.18 |
| 2025-12-18 | 2025-12-18 | 16111.58 |
| 2025-11-02 | 2025-12-17 | 15.4 |
| 2025-10-02 | 2025-11-01 | 15.41 |
| 2025-07-04 | 2025-10-01 | 11.23 |
| 2025-06-19 | 2025-07-03 | 11.24 |
| 2025-06-15 | 2025-06-17 | 5.34 |
| 2025-05-20 | 2025-06-14 | 5.39 |
| 2025-05-17 | 2025-05-19 | 682.67 |
| 2025-05-08 | 2025-05-16 | 689.69 |
| 2025-05-07 | 2025-05-07 | 682.49 |
| 2025-04-02 | 2025-05-06 | 4.49 |
| 2025-03-29 | 2025-04-01 | 5.5 |
| 2025-03-20 | 2025-03-28 | 6.91 |
| 2025-02-12 | 2025-02-21 | 2.22 |
| 2025-01-07 | 2025-02-11 | 0.78 |
| 2024-11-20 | 2024-12-05 | 2.09 |
| 2024-11-01 | 2024-11-19 | 0.29 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Gerameda, UAB (code 304861718) is a Private Limited Liability Company engaged in medical specialists activities. In 2025, the company generated revenue of €516.2K and net profit of €316.5K, with a profit margin of 61.3%. Revenue declined by 11.3% year on year from €582.1K in 2024, but it remained 21.8% above the 2023 level of €424.0K, showing continued growth over a two-year horizon despite the latest setback. Net profit followed the same pattern, rising from €271.4K in 2023 to €402.3K in 2024 before easing in 2025. The balance sheet remained very conservative, with total assets of €158.0K, equity of €157.4K and liabilities of only €661 at the end of 2025. Long-term assets amounted to €27.5K and short-term assets to €130.5K. Key ratios were strong, including ROE of 201.1%, ROA of 200.3% and asset turnover of 3.27x. Revenue per employee was €24.6K and profit per employee €15.1K.